Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emily Chan

Showing results (131-140 of 263) with videos related to

Pageof 27
Sort By:
European Journal of Immunology|January 31, 2009
Epithelial expression of human papillomavirus type 16 E7 protein results in peripheral CD8 T-cell suppression mediated by CD4+CD25+ T cellsSharmal Narayan, Allison Choyce, Richard Linedale, et al.
Pathology|May 1, 2016
Value of histopathology for predicting the post-operative complications of ileo-anal anastomosis (J-pouch) procedure in children with refractory ulcerative colitisDina El Demellawy, Soufiane El Hallani, Joseph de Nanassy, et al.
Plos Medicine|December 15, 2012
Preventing pandemics via international development: a systems approachTiffany L Bogich, Rumi Chunara, David Scales, et al.
American Journal of Clinical Oncology|March 17, 2017
A Phase II Study of Ganetespib as Second-line or Third-line Therapy for Metastatic Pancreatic CancerDana B Cardin, Ramya Thota, Laura W Goff, et al.
Medical Physics|October 24, 2024
Aggressiveness classification of clear cell renal cell carcinoma using registration-independent radiology-pathology correlation learningIndrani Bhattacharya, Karin Stacke, Emily Chan, et al.
European Journal of Cancer (Oxford, England : 1990)|January 9, 2013
Safety, pharmacokinetics and pharmacodynamics of the anti-A33 fully-human monoclonal antibody, KRN330, in patients with advanced colorectal cancerJeffrey R Infante, Johanna C Bendell, Laura Williams Goff, et al.
Histopathology|February 18, 2020
Molecular characterisation of metanephric adenomas beyond BRAF: genetic evidence for potential malignant evolutionEmily Chan, Bradley A Stohr, Nicole A Croom, et al.
Annals of Surgical Oncology|July 15, 2011
A phase II trial of neoadjuvant chemoradiation and local excision for T2N0 rectal cancer: preliminary results of the ACOSOG Z6041 trialJulio Garcia-Aguilar, Qian Shi, Charles R Thomas, et al.
Ebiomedicine|October 15, 2025
Alterations of the nasal and oral microbiota in multiple sclerosisShuqi Li, Federico Montini, Anya Song, et al.
American Journal of Clinical Oncology|January 11, 2011
Dual blockade of the EGFR and COX-2 pathways: a phase II trial of cetuximab and celecoxib in patients with chemotherapy refractory metastatic colorectal cancerEmily Chan, Bonnie Lafleur, Mace L Rothenberg, et al.
Pageof 27

Showing results (131-140 of 263) with videos related to

Sort By:
Pageof 27
European Journal of Immunology|January 31, 2009
Epithelial expression of human papillomavirus type 16 E7 protein results in peripheral CD8 T-cell suppression mediated by CD4+CD25+ T cellsSharmal Narayan, Allison Choyce, Richard Linedale, et al.
Pathology|May 1, 2016
Value of histopathology for predicting the post-operative complications of ileo-anal anastomosis (J-pouch) procedure in children with refractory ulcerative colitisDina El Demellawy, Soufiane El Hallani, Joseph de Nanassy, et al.
Plos Medicine|December 15, 2012
Preventing pandemics via international development: a systems approachTiffany L Bogich, Rumi Chunara, David Scales, et al.
American Journal of Clinical Oncology|March 17, 2017
A Phase II Study of Ganetespib as Second-line or Third-line Therapy for Metastatic Pancreatic CancerDana B Cardin, Ramya Thota, Laura W Goff, et al.
Medical Physics|October 24, 2024
Aggressiveness classification of clear cell renal cell carcinoma using registration-independent radiology-pathology correlation learningIndrani Bhattacharya, Karin Stacke, Emily Chan, et al.
European Journal of Cancer (Oxford, England : 1990)|January 9, 2013
Safety, pharmacokinetics and pharmacodynamics of the anti-A33 fully-human monoclonal antibody, KRN330, in patients with advanced colorectal cancerJeffrey R Infante, Johanna C Bendell, Laura Williams Goff, et al.
Histopathology|February 18, 2020
Molecular characterisation of metanephric adenomas beyond BRAF: genetic evidence for potential malignant evolutionEmily Chan, Bradley A Stohr, Nicole A Croom, et al.
Annals of Surgical Oncology|July 15, 2011
A phase II trial of neoadjuvant chemoradiation and local excision for T2N0 rectal cancer: preliminary results of the ACOSOG Z6041 trialJulio Garcia-Aguilar, Qian Shi, Charles R Thomas, et al.
Ebiomedicine|October 15, 2025
Alterations of the nasal and oral microbiota in multiple sclerosisShuqi Li, Federico Montini, Anya Song, et al.
American Journal of Clinical Oncology|January 11, 2011
Dual blockade of the EGFR and COX-2 pathways: a phase II trial of cetuximab and celecoxib in patients with chemotherapy refractory metastatic colorectal cancerEmily Chan, Bonnie Lafleur, Mace L Rothenberg, et al.
Pageof 27